Data Characteristics
Gene therapy AAV product data originates from preclinical research reports, clinical trial data, manufacturing batch records, quality control reports, and regulatory submissions. This data updates frequently, especially during clinical trials. Document structures typically include experimental protocols, raw data, analysis results, charts, and statistical reports. Fields cover vector titer, gene expression levels, host immune response, toxicity indicators, dosage, administration routes, and patient follow-up data. Units are diverse, including viral particles/mL, ng/mL, IU/mL, ΔCt values, molar concentrations, percentages, and timeframes (days/weeks/months).
Constraints on Workflow Orchestration
The diversity and high update frequency of AAV product data impose specific requirements on workflow orchestration. Data sources are disparate and varied in format. For example, raw mass spectrometry data comes as .raw files, while clinical reports are often .pdf or structured .csv. Workflows must support multi-source data ingestion and preprocessing. Key metrics like vector titer and gene expression levels often link to multiple experimental data points, requiring complex data aggregation and calculation capabilities. High update frequency necessitates frequent incremental updates to the knowledge base. Workflows must identify and handle associations and conflicts between new and old data. Finally, the extensive use of specialized terminology, abbreviations, and heterogeneous data from different experimental methods demands highly domain-specific configurations for information extraction and entity recognition.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
maxContext | 2000–3000 token | Ensures accommodation of key experimental data, method descriptions, and result summaries, preventing information loss due to context truncation. |
Chunk size (Segment Length) | 400–600 characters (characters) | Balances segment completeness with recall precision, aiding the LLM in understanding full descriptions of individual experiments or metrics. |
Recall count (Recall Count) | Top 8–12 entries (top 8–12 items) | AAV product inquiries may involve comparing multiple indicators. Increased recall covers a broader range of information. |
Similarity threshold (Similarity Threshold) | 0.78–0.85 | Domain-specific terminology has high similarity. A higher threshold filters out irrelevant general descriptions. |
Rerank result count (Reranked Return Count) | 5 entries (items) | Reranks recall results, ensuring the most relevant core data and conclusions are prioritized. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds (seconds) | Processing large experimental reports and clinical trial documents may take significant time, preventing file parsing timeouts. |
Common Pitfalls
- A workflow functioning correctly in the preview page but failing in the chat interface often indicates that certain nodes (e.g., external API calls) in the workflow cannot execute due to permissions or network configuration issues in the chat environment, leading to process interruption.
- The model still outputs
<think>tags even after disabling thought output. This likely means the model internally generates thought processes. More thorough suppression or filtering is needed at the model level or in post-processing. - A low
Similarity threshold(similarity threshold) can lead to generalized or irrelevant answers. The AAV field has dense specialized terminology with synonyms or near-synonyms. A low threshold introduces significant noise, affecting consultation accuracy.
Validation Steps
- For typical queries, check workflow execution logs. Confirm that all data source nodes (e.g., knowledge base retrieval, API calls) successfully return data, and the returned data matches expectations.
- Simulate queries for key indicators (e.g., vector titer, gene expression levels). Check if the model's output accurately cites specific values and units from the knowledge base and verify against original documents.
- For multi-step reasoning queries, such as "What is the immunogenicity of a specific AAV product batch, and how does it compare to the control group?", check if the workflow correctly associates and integrates immunogenicity data and control group data, providing a logical comparative analysis that aligns with expert expectations.
Note: The values provided are common starting points. Measure them against your own samples for optimal performance.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.